Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10013291HBVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS10012007HBVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS30003943HIVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS30009207HIVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS30086264HIVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS30076416HIVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS30083332HIVENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS44001718HTLV-1ENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TVIS44039289HTLV-1ENSG00000112038.18protein_codingOPRM1NoNo4988B8K2Q5
G8XRH4
G8XRH5
L0E130
P35372
TCGA Plot Options
Drug Information
GeneOPRM1
DrugBank IDDB09272
Drug NameEluxadoline
Target IDBE0000770
UniProt IDP35372
Regulation Typeagonist
PubMed IDs25261794; 23583433
CitationsFujita W, Gomes I, Dove LS, Prohaska D, McIntyre G, Devi LA: Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochem Pharmacol. 2014 Dec 1;92(3):448-56. doi: 10.1016/j.bcp.2014.09.015. Epub 2014 Sep 28.@@Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS: Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006. Epub 2013 Apr 9.
GroupsApproved; Investigational
Direct ClassificationPhenylalanine and derivatives
SMILESCOC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
Pathways
PharmGKB
ChEMBLCHEMBL2159122